Up regulation of NGF, trkA, fas, down regulation of bcl-2, and induction of apoptosis by propentofylline in human glioma cell lines

Brain and Nerve

Volumn 48, Issue 11, 1996, Pages 1022-1028

  Kamada, Hajime ^a   Murakami, Hiromi ^a   Satone, Akira ^a   Ikeda, Masahiko ^a   Ide, Wataru ^a   Hashimoto, Ikuo ^a   Ukita, Hiroyuki ^a  

^a Hokuto Hospital   (Japan)

Author keywords

Akihiko matsumoto; Apoptosis; Bcl 2; Fas; Hideshi yamaguchi; Human glioma cells; NGF; Propentofylline

Indexed keywords

DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; NERVE GROWTH FACTOR; PROPENTOFYLLINE; PROTEIN; PROTEIN TYROSINE KINASE;

APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DIAGNOSIS; DOWN REGULATION; ETIOLOGY; GENE; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; DOWN-REGULATION; GLIOMA; HUMANS; MICE; NERVE GROWTH FACTORS; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; TUMOR CELLS, CULTURED; UP-REGULATION; XANTHINES;

EID: 0029906675     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K. Goeddel DV, Rosenthal A Neurotrophin-5 A novel neurotrophic factor that activates trk and trkB. Neuron 1 857-866, 1991
2. Chao MV Ceramid A potential second messenger in the nervous system. Mol Cell Neurosci 6 91-96, 1995
3. Das R, Reddy KP. Chatterjee D, Andrews DW Identification of a novel Bcl-2 related gene, BRAG 1, in human glioma. Oncogene 12 947-951, 1996
4. De Leo J. Schubert P, Kreutzberg G W Propentofylline (HWA285) protects hippocampal neurons of Mongolian gerbils against ischémie damage in the presence of an adenosine antagonist. Neurosci Lett 84 307-311, 1988
5. Franke T F. Yang S-L Chan TO. Datta K, Kazlauskas A. Morrison DK. Kaplan DR. Tsichlis PN The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF activated phosphatidylinositol 3' kinase. Cell 81 727 736. 1995
6. Fraser A, McCarthy, Kvan Gl Biochemistry of cell death. Curr Opin Neurobiol 671-80. 1996
7. Fuji K, Hiramatsu M. Kameyama T, Nabeshima T Fffects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats. Euro J Pharmacol 236411 -417. 1993
8. Goto M. Demura N, Sakaguchi T Effects of propentofylline on disorder of learning and memory in rodents. Jpn J Pharmacol 43373-378, 1987
9. Hohn A. Leibrock J. Bailey K, Barde Y A Identification and characterization of a novel member of the nerve growth factor/brain derived neurotrophic factor family. Nature 344339 341, 1990
10. Ilollstein M. Sidransky D, Voqelstein B, Harris CC p.r)3 mutations in human cancers. Science 253 19 f)3, 1991
11. Jäättelä M, Benedict M, Tewari M, Shayman JA, Dixit VM Bel x and Bel 2 inhibit TNF and Fas induced apoptosis and activation of phospholipase A., in breast carcinoma cells. Oncogene 10 22972305, 1995
12. Kaplan DR, Martin Zanca D, Parada LF Tyro sine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350158 160. 1991
13. Kaplan DR. Ilempstead BL. Martin- Zanca D, Chao MV. Parada LF The trk proto-oncogene product A signal transducing receptor for nerve growth factor. Science 252554-558, 1991
14. Lange Carter CA, Johnson GL Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 265 1458-1461. 1994
15. Leibrock J. Lottspeich F. Hohn A. Hofer M. Hengerer B, Masiakowski P, Thoenen II. Barde YA Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341149-152, 1989
16. Miki S, Inokuchi N, Nakayama T, Yasoshima A, Deguchi II .Uemiya M, Uemura T. Yamamoto M Kffect of propentofylline on the production of IL-6 by glioblastoma cells in vitro. J Nissei Hosp 18 132 135. 1990
17. Miyashita T. Krajewski S, Krajewska M, Wang HCi. Lin IIK Tumor suppressor p53 is a regulator of bel 2 and bax gene expression in vitro and in vivo. Oncogene 9 1799 1805. 1994
18. Mrsulja BB. Micic DY, Djuricic BM Gerbil stroke model An approach to the study of therapeutic aspects of postischemic brain edema. Adv Biosci 4345 62. 1983
19. Obeid L.Yl. Linardic CM, Karolak LA. Hannun YA Programmed cell death induced by ceramide. Science 2591709 1771. 1993
20. Pang L. Sawada T, Decker SJ. Saltiel AK Inhibition of MAP kinase kinase blocks the differentiation of PC 12 cells induced by nerve growth factor. J Biol Chem 270 13585-13.18. 1995
21. Rabin SJ, Cleghon V, Kaplan DR S NT. a differentiation-specific target of neurotrophic factor induced tyrosine kinase activity in neurons and PC12 cells. Mol Cell Biol 13 2203 2213. 1993
22. Shinoda I, Furukawa Y, Furukawa S Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial culls. Biochem Pharmacol 391813-1816, 1990
23. Stephens KM. Loeb DM. Copeland TD, Pawson 'I'. Greene LA. Kaplan DR Trk receptors use redundant signal transduction pathways involving She and PLC 7 1 to mediate NGF responses. Neuron 12 691 705. 1994
24. Suda T. Takahashi T. Holstein P. Nagata S Molecular cloning and expression of the Fas ligancl. a novel member of the tumor necrosis facor family. Cell 751169 1178, 1993
25. Trauth BC. Klas C. Peters AMJ. Matzku S. Möller P. Falk W, Debatin K M, Krammer PH Mono clonal antibody mediated tumor regression by induction of apoptosis. Science 245301 305. 19X9
26. Tsujimoto Y. Croce CM Analysis of the structure, transcripts, and protein products of Bel 2. the gene involved in human follicular lymphoma. Proc N at I Acad Sei USA H3 5214 5218. 1986